Healthcare

SINGAPORE (Mar 18): It started the day after I returned to Penang from Singapore, a visit filled with the usual shopping and dining, as well as catching up with friends and relatives. An earache prompted a quick visit to the GP, but it didn’t mar the fa

SINGAPORE (Mar 11): Soochow CSSSD Capital Markets (SCCM) is starting coverage on OUE Lippo Healthcare (OUE LH) at “buy” with a target price of 8.8 cents, while forecasting a 25.2% earnings per share (EPS) CAGR from FY19-22E as the group enters a “du

SINGAPORE (Mar 4): Singapore may have accumulated huge surpluses during the current term of government, but that does not indicate an upcoming spending spree. The surpluses will also not be used to stall an impending Goods and Services Tax hike due to hap

SINGAPORE (Mar 1): Hyphens Pharma International has announced earnings of $0.8 million for the 4Q ended Dec 2018, rising 31.9% from $0.6 million in 4Q17 in the absence of one-off IPO expenses incurred from the year before.  

SINGAPORE (Feb 25): Raffles Medical Group (RMG) announced $71.1 million in earnings for FY18, rising a marginal 0.4% from $70.8 million in FY17 as higher tax expenses and additional depreciation from the recently-completed Raffles Specialist Centre contin

SINGAPORE (Feb 20): Biolidics Limited has established a strategic partnership with Sysmex Corporation, a Tokyo Stock Exchange-listed supplier of hematology instruments, to collaborate on the development of laboratory assays in the field of circulating tum

SINGAPORE (Feb 19): Singapore Medical Group (SMG) posted a 17.2% rise in 4Q18 earnings to $2.9 million from $2.5 million a year ago, driven by increased revenue contributions from the health and diagnostic & aesthetic business segments.

SINGAPORE (Jan 31): Singapore Medical Group (SMG) subsidiary HiDoc today launched its new telehealth platform, which is meant to provide first-of-its-kind telehealth and video conferencing services while giving accredited specialists access to patient hea

SINGAPORE (Jan 14): Best World has agreed to acquire a 15% stake in Celligenics, a biomedical A*STAR spin-off start-up, in two investment phases.  

SINGAPORE (Jan 11): The headwinds of geopolitical stresses, market turbulence and policy uncertainties in the major global economies are no friend to small, open and trade-­dependent Singapore.